• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与无症状和轻度症状COVID-19患者肾功能动态变化相关的生物标志物

Biomarkers Linked with Dynamic Changes of Renal Function in Asymptomatic and Mildly Symptomatic COVID-19 Patients.

作者信息

Chang Ya-Chieh, Tsai Ping-Huang, Chou Yu-Ching, Lu Kuo-Cheng, Chang Feng-Yee, Wu Chia-Chao

机构信息

Department of Internal Medicine, Division of Nephrology, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.

Department of Internal Medicine, Division of Nephrology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.

出版信息

J Pers Med. 2021 May 19;11(5):432. doi: 10.3390/jpm11050432.

DOI:10.3390/jpm11050432
PMID:34069451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159130/
Abstract

The catastrophic coronavirus disease 2019 (COVID-19) pandemic is currently a critical global issue. One well-known complication of COVID-19 in severe cases is acute kidney injury, but no research has given a description of its impact on the kidney in patients with mild symptoms. We explore the renal function changes in mild COVID-19 patients. This retrospective, single-center study included 27 participants with laboratory-detected severe acute respiratory syndrome coronavirus two (SARS-CoV-2) infection who were admitted to the Tri-Service General Hospital from 4 February to 26 May 2020 and analyzed their clinical features, radiological findings, and laboratory data. Data collected upon admission and discharge showed a median estimated glomerular filtration rate (eGFR) of 106.7 mL/min/1.732 m and 112.2 mL/min/1.732 m, respectively, with a -value of 0.044. A correlation between renal function and the severity of infection was also found and was statistically significant upon admission. Patients with a lower lymphocyte count or higher C-reactive protein, neutrophil count, and neutrophil-to-lymphocyte ratio presented with a decreased eGFR during their early infection phase. The biomarkers (CRP and NLR) may be linked with dynamic changes of renal function in COVID-19 patients who are asymptomatic or have mild symptoms.

摘要

2019年冠状病毒病(COVID-19)大流行目前是一个严峻的全球问题。COVID-19严重病例的一个众所周知的并发症是急性肾损伤,但尚无研究描述其对轻症患者肾脏的影响。我们探讨轻症COVID-19患者的肾功能变化。这项回顾性单中心研究纳入了2020年2月4日至5月26日入住三军总医院的27名经实验室检测确诊感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的参与者,并分析了他们的临床特征、影像学表现和实验室数据。入院和出院时收集的数据显示,估计肾小球滤过率(eGFR)中位数分别为106.7 mL/min/1.732 m²和112.2 mL/min/1.732 m²,P值为0.044。还发现肾功能与感染严重程度之间存在相关性,且入院时具有统计学意义。淋巴细胞计数较低或C反应蛋白、中性粒细胞计数及中性粒细胞与淋巴细胞比值较高的患者在感染早期eGFR降低。生物标志物(CRP和NLR)可能与无症状或轻症COVID-19患者肾功能的动态变化有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef97/8159130/1b028d4a265b/jpm-11-00432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef97/8159130/86b97aff62ee/jpm-11-00432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef97/8159130/1b028d4a265b/jpm-11-00432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef97/8159130/86b97aff62ee/jpm-11-00432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef97/8159130/1b028d4a265b/jpm-11-00432-g002.jpg

相似文献

1
Biomarkers Linked with Dynamic Changes of Renal Function in Asymptomatic and Mildly Symptomatic COVID-19 Patients.与无症状和轻度症状COVID-19患者肾功能动态变化相关的生物标志物
J Pers Med. 2021 May 19;11(5):432. doi: 10.3390/jpm11050432.
2
[Correlation between early inflammation indicators and the severity of coronavirus disease 2019].[2019年冠状病毒病早期炎症指标与疾病严重程度的相关性]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Feb;33(2):145-149. doi: 10.3760/cma.j.cn121430-20200515-00387.
3
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.肾功能对 COVID-19 患者入院的影响:对国际 HOPE COVID-19(COVID-19 健康结果预测评估)登记的分析。
J Nephrol. 2020 Aug;33(4):737-745. doi: 10.1007/s40620-020-00790-5. Epub 2020 Jun 29.
4
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.新冠肺炎患者 D-二聚体和中性粒细胞-淋巴细胞比值的动态变化作为预后生物标志物。
Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7.
5
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病(COVID-19)住院儿科患者的临床和免疫特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895.
6
[Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].[中性粒细胞/淋巴细胞比值对重症新型冠状病毒肺炎患者心肌损伤的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):572-579. doi: 10.3760/cma.j.cn112148-20200422-00336.
7
Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.住院的 2019 冠状病毒病患者血液学参数的动态特征及其临床意义。
Clin Chem Lab Med. 2020 Jul 28;58(8):1365-1371. doi: 10.1515/cclm-2020-0411.
8
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.摩洛哥卡萨布兰卡新冠肺炎患者严重程度的预测因素
Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716.
9
Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery.表达谱揭示了 SARS-CoV-2 引起的潜在肾损伤:对 ACE2 的系统分析及由此发现得出的临床经验。
Aging (Albany NY). 2020 Nov 21;13(8):10821-10832. doi: 10.18632/aging.202224.
10
Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).中性粒细胞与淋巴细胞比值和 C 反应蛋白水平对 2019 冠状病毒病(COVID-19)的应用价值。
Scand J Clin Lab Invest. 2020 Nov;80(7):536-540. doi: 10.1080/00365513.2020.1803587. Epub 2020 Aug 17.

引用本文的文献

1
Global geographic and socioeconomic disparities in COVID-associated acute kidney injury: a systematic review and meta-analysis.新冠相关急性肾损伤的全球地理和社会经济差异:一项系统综述和荟萃分析。
J Glob Health. 2025 Jul 25;15:04166. doi: 10.7189/jogh.15.04166.
2
Novel Advancements in COVID-19 and Neuroscience.新型冠状病毒肺炎与神经科学的新进展
J Pers Med. 2024 Jan 28;14(2):143. doi: 10.3390/jpm14020143.
3
Association of Neutrophil/Lymphocyte Ratio and Neutrophil/Lymphocyte Platelet Ratio With Acute Kidney Injury in Severe COVID-19.

本文引用的文献

1
The role of C-reactive protein as a prognostic marker in COVID-19.C反应蛋白在2019冠状病毒病中作为预后标志物的作用。
Int J Epidemiol. 2021 May 17;50(2):420-429. doi: 10.1093/ije/dyab012.
2
Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients.中性粒细胞与淋巴细胞比值可预测血液透析患者COVID-19的短期预后。
Clin Kidney J. 2020 Nov 21;14(1):124-131. doi: 10.1093/ckj/sfaa194. eCollection 2021 Jan.
3
ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients.
中性粒细胞/淋巴细胞比值及中性粒细胞/淋巴细胞与血小板比值与重症新型冠状病毒肺炎急性肾损伤的关系
Cureus. 2023 Aug 21;15(8):e43873. doi: 10.7759/cureus.43873. eCollection 2023 Aug.
4
Leading Pathogens Involved in Co-Infection and Super-Infection with COVID-19: Forensic Medicine Considerations after a Systematic Review and Meta-Analysis.新型冠状病毒肺炎合并感染和重叠感染中的主要病原体:系统评价与Meta分析后的法医学考量
Pathogens. 2023 Apr 27;12(5):646. doi: 10.3390/pathogens12050646.
5
Influence of Renal Dysfunction on the Differential Behaviour of Procalcitonin for the Diagnosis of Postoperative Infection in Cardiac Surgery.肾功能不全对降钙素原在心脏手术术后感染诊断中鉴别行为的影响。
J Clin Med. 2022 Dec 7;11(24):7274. doi: 10.3390/jcm11247274.
6
Editorial: Nutraceuticals for the recovery of COVID-19 patients.社论:用于COVID-19患者康复的营养保健品
Front Nutr. 2022 Nov 14;9:1054632. doi: 10.3389/fnut.2022.1054632. eCollection 2022.
7
SARS-CoV-2 versus other minor viral infection on kidney injury in asymptomatic and mildly symptomatic patients.新型冠状病毒与其他轻微病毒感染对无症状和轻度症状患者肾脏损伤的影响。
Virulence. 2022 Dec;13(1):1349-1357. doi: 10.1080/21505594.2022.2107602.
8
Predicting Intensive Care Unit Admission for COVID-19 Patients from Laboratory Results.从实验室结果预测 COVID-19 患者入住重症监护病房。
Dis Markers. 2022 May 26;2022:4623901. doi: 10.1155/2022/4623901. eCollection 2022.
血管紧张素转换酶2(ACE2)在肾脏和睾丸中的表达可能导致COVID-19患者的肾脏和睾丸感染。
Front Med (Lausanne). 2021 Jan 13;7:563893. doi: 10.3389/fmed.2020.563893. eCollection 2020.
4
C-reactive protein and clinical outcomes in patients with COVID-19.C 反应蛋白与 COVID-19 患者的临床结局。
Eur Heart J. 2021 Jun 14;42(23):2270-2279. doi: 10.1093/eurheartj/ehaa1103.
5
Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab.监测接受托珠单抗治疗的2019冠状病毒病患者的中性粒细胞与淋巴细胞比值。
Ann Allergy Asthma Immunol. 2021 Mar;126(3):306-308. doi: 10.1016/j.anai.2020.12.014. Epub 2020 Dec 30.
6
C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19.C 反应蛋白作为 COVID-19 住院患者的预后指标。
PLoS One. 2020 Nov 20;15(11):e0242400. doi: 10.1371/journal.pone.0242400. eCollection 2020.
7
SARS-CoV-2 viral load is associated with increased disease severity and mortality.SARS-CoV-2 病毒载量与疾病严重程度和死亡率的增加有关。
Nat Commun. 2020 Oct 30;11(1):5493. doi: 10.1038/s41467-020-19057-5.
8
Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.中性粒细胞与淋巴细胞比值对 COVID-19 的预后意义。
Eur J Clin Invest. 2021 Jan;51(1):e13404. doi: 10.1111/eci.13404. Epub 2020 Sep 25.
9
Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity.中性粒细胞/淋巴细胞比值-COVID-19 肺炎严重程度的标志物。
Int J Clin Pract. 2021 Apr;75(4):e13698. doi: 10.1111/ijcp.13698. Epub 2021 Jan 12.
10
COVID-19 length of hospital stay: a systematic review and data synthesis.COVID-19 住院时间:系统评价和数据综合。
BMC Med. 2020 Sep 3;18(1):270. doi: 10.1186/s12916-020-01726-3.